Taiwan FDA registration 73323c6332e221e4ffdc5f3fab3e0ac1
RAMP D-dimer Assay
TW: “倫普” 纖維蛋白崩解產品分析試劑組
Taiwan·Risk Class 2·MD·RESPONSE BIOMEDICAL CORPORATION·Registered Oct 20, 2015 – Oct 20, 2025ExpiredRegistration details
- Analysis ID
- 73323c6332e221e4ffdc5f3fab3e0ac1
- License Form
- Ministry of Health Medical Device Import No. 027885
- Customs Code
- DHA05602788501
Company information
- Manufacturer
- RESPONSE BIOMEDICAL CORPORATION
- Manufacturer Country
- Canada
- Authorized Representative
- RECHI CO., LTD.
Product details
- Intended Use
- This product is used for the quantitative detection of human fiber degradation product (FDP) dimer in EDTA anticoagulant whole blood collection blood collection blood collection blood spectrum blood plasma plasma quantitative coagulation blood spectrum blood plasma blood plasma quantitative coagulation blood collection blood plasma This product is an in vitro diagnostic reagent.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B7320 Fibrinogen Fibrinogen Breakdown Product Analysis
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Oct 20, 2015
- Expiry Date
- Oct 20, 2025
About this record
Access comprehensive regulatory information for RAMP D-dimer Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 73323c6332e221e4ffdc5f3fab3e0ac1 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices